Rani Therapeutics Hldgs Stock (NASDAQ: RANI) stock price, news, charts, stock research, profile.
You can purchase shares of Rani Therapeutics Hldgs (NASDAQ:RANI) through any online brokerage.
Other companies in Rani Therapeutics Hldgs’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Nutriband (NASDAQ:NTRB) and VYNE Therapeutics (NASDAQ:VYNE).
Rani Therapeutics Hldgs has a consensus price target of $12.67.
The stock price for Rani Therapeutics Hldgs (NASDAQ: RANI) is $2.08 last updated November 25, 2024 at 7:25 AM EST.
There are no upcoming dividends for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.